Lucid Diagnostics Balans Gezondheid
Financiële gezondheid criteriumcontroles 3/6
Lucid Diagnostics has a total shareholder equity of $16.0M and total debt of $11.2M, which brings its debt-to-equity ratio to 70.1%. Its total assets and total liabilities are $34.1M and $18.1M respectively.
Belangrijke informatie
70.1%
Verhouding schuld/eigen vermogen
US$11.20m
Schuld
Rente dekkingsratio | n/a |
Contant | US$26.28m |
Aandelen | US$15.98m |
Totaal verplichtingen | US$18.13m |
Totaal activa | US$34.11m |
Recente financiële gezondheidsupdates
Recent updates
We're A Little Worried About Lucid Diagnostics' (NASDAQ:LUCD) Cash Burn Rate
May 09Lucid Diagnostics (NASDAQ:LUCD) Will Have To Spend Its Cash Wisely
Dec 15Lucid Diagnostics launches stage II lucid test center in California, Texas, Florida, and Ohio
Aug 11We're Keeping An Eye On Lucid Diagnostics' (NASDAQ:LUCD) Cash Burn Rate
Jul 07Analyse van de financiële positie
Kortlopende schulden: LUCD's short term assets ($27.9M) exceed its short term liabilities ($16.0M).
Langlopende schulden: LUCD's short term assets ($27.9M) exceed its long term liabilities ($2.2M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: LUCD has more cash than its total debt.
Schuld verminderen: LUCD's debt to equity ratio has increased from 0% to 70.1% over the past 5 years.
Balans
Analyse van de cashflow
Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.
Stabiele cash runway: LUCD has less than a year of cash runway based on its current free cash flow.
Voorspelling contante baan: LUCD has less than a year of cash runway if free cash flow continues to reduce at historical rates of 41.8% each year